July 8 (Reuters) - Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two ...

It clears out toxic proteins in the brain that cause memory loss ...

Medicine may slow decline for some, but dementia care must also protect dignity, identity and story when speech begins to ...

A substance that worsens dementia has become a "switch" that initiates treatment. KAIST researchers have developed a new ...

Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in ...

A diabetes drug was linked to a surprising effect on the risk of dementia.

In an exciting breakthrough, researchers have identified cancer drugs that might reverse the effects of Alzheimer's disease in the brain. By analyzing gene expression in brain cells, they discovered ...

Health chiefs have been accused of exaggerating the cost of administering breakthrough Alzheimer’s drugs, resulting in their rollout being blocked.

Health chiefs must act now to allow millions of people to benefit from “statins for the brain”, scientists say.

Merck cited business reasons for the discontinuation of the investigational drug.